Atria Wealth Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.45M	Sell	3,254 -3,402	-51%	-$1.57M	0.03%	510
2025 Q1	$3.23M	Sell	6,656 -556	-8%	-$259K	0.04%	465
2024 Q4	$2.9M	Sell	7,212 -2,523	-26%	-$1.17M	0.03%	513
2024 Q3	$4.53M	Sell	9,735 -987	-9%	-$474K	0.05%	376
2024 Q2	$5.03M	Buy	10,722 +107	+1%	+$46.4K	0.06%	344
2024 Q1	$4.44M	Buy	10,615 +21	+0.2%	+$8.88K	0.05%	373
2023 Q4	$4.31M	Buy	10,594 +8	+0.1%	+$2.96K	0.05%	353
2023 Q3	$3.68M	Buy	10,586 +200	+2%	+$69.9K	0.05%	373
2023 Q2	$3.65M	Buy	10,386 +830	+9%	+$280K	0.05%	372
2023 Q1	$3.01M	Buy	9,556 +732	+8%	+$220K	0.04%	405
2022 Q4	$2.55M	Sell	8,824 -776	-8%	-$237K	0.04%	431
2022 Q3	$2.78M	Buy	9,600 +5,009	+109%	+$1.44M	0.05%	374
2022 Q2	$1.29M	Sell	4,591 -1,435	-24%	-$384K	0.03%	588
2022 Q1	$1.57M	Buy	+6,026	New	+$1.43M	0.03%	557